Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling
- PMID: 16829804
- DOI: 10.1097/01.iae.0000236469.71443.aa
Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling
Abstract
Purpose: To report the use of the dye brilliant blue G (BBG) for staining of the internal limiting membrane (ILM) during macular hole (MH) and epiretinal membrane (ERM) surgery.
Methods: This study was designed as an interventional, noncomparative, prospective, clinical case series. Twenty eyes from 20 consecutive patients with MH or ERM underwent BBG-assisted ILM and ERM removal. In MH cases, a posterior vitreous detachment was created, followed by the injection of 0.25 mg/mL BBG solution into the vitreous cavity and immediate washout of the BBG. This technique improved visualization of the ILM, enabling peeling and surgery to be performed successfully. However, in ERM cases, staining of the ERM could not be confirmed at this concentration. Finally, the ILM including the ERM was removed in all cases. Preoperative and postoperative ophthalmic examinations were performed.
Results: Postoperatively, 17 patients (85%) had visual acuity improved by at least 2 Snellen lines. No adverse effects were observed postoperatively during the observation period (mean follow-up +/- SD, 7.3 +/- 1.0 months).
Conclusions: BBG selectively stains the ILM. This technique can facilitate the management of MH and ERM surgery without any adverse effects, as was shown in this short-term study.
Comment in
-
What are vitreoretinal surgeons dyeing for?Retina. 2006 Jul-Aug;26(6):599-601. doi: 10.1097/01.iae.0000236467.25701.4e. Retina. 2006. PMID: 16829799 No abstract available.
Similar articles
-
Double staining with brilliant blue G and double peeling for epiretinal membranes.Ophthalmology. 2009 Jul;116(7):1370-6. doi: 10.1016/j.ophtha.2009.01.024. Epub 2009 May 8. Ophthalmology. 2009. PMID: 19427701
-
Indocyanine green-assisted internal limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study.Am J Ophthalmol. 2004 Aug;138(2):194-9. doi: 10.1016/j.ajo.2004.03.013. Am J Ophthalmol. 2004. PMID: 15289126
-
Idiopathic macular hole surgery with low-concentration infracyanine green-assisted peeling of the internal limiting membrane.Am J Ophthalmol. 2006 Nov;142(5):771-6. doi: 10.1016/j.ajo.2006.06.032. Am J Ophthalmol. 2006. PMID: 17056361
-
[Macular hole surgery with and without internal limiting membrane peeling].Arch Soc Esp Oftalmol. 2003 Mar;78(3):159-64. Arch Soc Esp Oftalmol. 2003. PMID: 12677493 Review. Spanish.
-
Intravitreal staining of the internal limiting membrane using indocyanine green in the treatment of macular holes.Ophthalmologica. 2005 Sep-Oct;219(5):251-62. doi: 10.1159/000086107. Ophthalmologica. 2005. PMID: 16123549 Review.
Cited by
-
The structural effect of intravitreal Brilliant blue G and Indocyanine green in rats eyes.Eye (Lond). 2013 Mar;27(3):425-31. doi: 10.1038/eye.2012.260. Epub 2012 Nov 30. Eye (Lond). 2013. PMID: 23196646 Free PMC article.
-
Evaluating retinal toxicity of a new heavy intraocular dye, using a model of perfused and isolated retinal cultures of bovine and human origin.Graefes Arch Clin Exp Ophthalmol. 2012 Jul;250(7):1013-22. doi: 10.1007/s00417-012-1989-5. Epub 2012 Mar 28. Graefes Arch Clin Exp Ophthalmol. 2012. PMID: 22450526
-
Macular toxicity of vital dye after pars plana vitrectomy for idiopathic epiretinal membrane: A case report.Am J Ophthalmol Case Rep. 2022 May 18;27:101588. doi: 10.1016/j.ajoc.2022.101588. eCollection 2022 Sep. Am J Ophthalmol Case Rep. 2022. PMID: 35637750 Free PMC article.
-
Outcomes of 23-gauge pars plana vitrectomy and internal limiting membrane peeling with brilliant blue in macular hole.Clin Ophthalmol. 2011;5:1177-83. doi: 10.2147/OPTH.S22381. Epub 2011 Aug 19. Clin Ophthalmol. 2011. PMID: 21887101 Free PMC article.
-
Comparisons of cone electroretinograms after indocyanine green-, brilliant blue G-, or triamcinolone acetonide-assisted macular hole surgery.Graefes Arch Clin Exp Ophthalmol. 2014 Sep;252(9):1423-33. doi: 10.1007/s00417-014-2594-6. Epub 2014 Mar 2. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 24584708 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical